Scout Investments, Inc., released the Carillon Scout Mid Cap Fund’s second-quarter 2025 investor letter. The Russell Midcap Index saw positive returns despite a sell-off after the Liberation Day tariff announcement, allowing more time for negotiations. Check out the fund’s top five holdings to see its best picks in 2025.

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) was highlighted in the Carillon Scout Mid Cap Fund’s second-quarter 2025 investor letter. The medical technology company had a one-month return of 1.99% and a market capitalization of $20.572 billion on September 9, 2025. Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stock closed at $103.85 per share.

Carillon Scout Mid Cap Fund discussed Zimmer Biomet Holdings, Inc. (NYSE: ZBH) in its second quarter 2025 investor letter. Despite overall solid earnings, Zimmer faced challenges due to dilution from an acquisition and potential tariff impacts. The company lost market share in knee replacements, but a new release cycle could boost revenue growth.

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is not among the 30 Most Popular Stocks Among Hedge Funds. 40 hedge fund portfolios held the stock at the end of the second quarter, up from 52 in the previous quarter. Zimmer Biomet Holdings, Inc. (NYSE: ZBH) reported net sales of $2.077 billion in the second quarter, showing potential as an investment.

Read more at Yahoo Finance: Zimmer Biomet Holdings (ZBH) Fell due to Reduced Guidance